Emerging treatment options for patients with p53-pathway-deficient CLL

by Marisa J. L. Aitken, Hun J. Lee, Sean M. Post
Published 2019-12-01

Prognostic and therapeutic implications of measurable residual disease in acute myeloid leukemia

by Marisa J. L. Aitken, Farhad Ravandi, Keyur P. Patel, Nicholas J. Short
Published 2021-09-01

The Eµ-hnRNP K Murine Model of Lymphoma: Novel Insights into the Role of hnRNP K in B-Cell Malignancies

by Prerna Malaney, María Velasco-Estevez, Pedro Aguilar-Garrido, Marisa J. L. Aitken, Lauren E. Chan, Xiaorui Zhang, Sean M. Post, Miguel Gallardo
Published 2021-04-01

Overexpression of CD200 is a Stem Cell-Specific Mechanism of Immune Evasion in AML

by R Eric Davis, Marina Konopleva, Natalia Baran, Gheath Al-Atrash, Naval Daver, Shelley Herbrich, Tianyu Cai, Connie Weng, Marisa J L Aitken, Sean M Post, Jared Henderson, Chunhua Shi, Guillame Richard-Carpentier, Guy Sauvageau, Keith Baggerly, Dongxing Zha
Published 2021-07-01